MétaCan
Menu
Back to cohort

Role of the transcription factor Yin Yang 1 in non‐small cell lung cancer

2016· article· en· W4389025903 on OpenAlexaff
Olivier Boucherat, Sophie Chabot, Alice Bourgeois, Steeve Provencher, Roxane Paulin, François Maltais, Sébastien Bonnet

Bibliographic record

VenueThe FASEB Journal · 2016
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicRNA modifications and cancer
Canadian institutionsInstitut universitaire de cardiologie et de pneumologie de Québec
Fundersnot available
KeywordsLung cancerCancer researchAdenocarcinomaEctopic expressionBiologyCell growthSmall interfering RNACancerImmunohistochemistryTranscription factorCellA549 cellMedicinePathologyOncologyTransfectionInternal medicineCell cultureGene

Abstract

fetched live from OpenAlex

Background Lung cancer is the most prevalent cancer type worldwide by both diagnosis and mortality, with non‐small cell lung cancers (NSCLCs) featuring as the most common histological subtype, the latter of which consists of squamous (epidermoid), adenocarcinoma, and large cell carcinoma. Rates of lung cancer will continue to rise owing to high levels of cigarette consumption and aging populations. Despite increased surgical resection rates, optimization of chemo‐radiotherapy and the introduction of targeted therapies, the treatment outcome for NSCLC remains poor. Therefore, identification of new molecular targets, which are essential for proliferation of tumor cells, will benefit both treatment and chemoprevention of NSCLC. The Yin Yang 1 (YY1) transcription factor has a pivotal role in normal biological processes such as development, differentiation, replication and cell proliferation exerting its effects on a huge number of genes involved in these processes. Due to its functions during lung morphogenesis, we hypothesize that YY1 is overexpressed and contributes to the pro‐proliferative and anti‐apoptotic phenotype of cancerous cells. Method/Results Expression level of YY1 was first examined by immunohistochemistry (n=5) and western blot (n=11) in resected tumor tissue of NSCLC patients (stages I–III) and compared to adjacent non‐cancerous lung tissue. Results showed that YY1 expression is significantly increased in squamous cell carcinoma and adenocarcinoma of the lung. A greater proliferation rate (Ki67 labeling) was associated with strong YY1 expression in these human lung tumors. In vitro, transient transfection experiments with A549 lung adenocarcinoma cells showed that depletion of YY1 levels by short interfering RNA reduced proliferation (Ki67 labeling and MTT assay, p<0,001), resistance to apoptosis (Annexin V assay, cleaved caspase‐3 expression, p<0,05) and migration (wound healing assay, p<0,001). In addition, YY1 knockdown improved in vitro NSCLC sensitivity to Etoposide/Cisplatin, two chemotherapeutic agents. Conclusion Taken together, these findings suggest that up‐regulation of YY1 plays an important role in the development of lung cancer. Susceptibility of YY1‐depleted A549 cells and YY1 heterozygous mice to induce tumors is currently under investigation. Analysis of YY1 expression in a larger cohort of patients may reveal prognostic information and deserves further study. Support or Funding Information None

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.010
GPT teacher head0.233
Teacher spread0.223 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueThe FASEB JournalSame topicRNA modifications and cancerFrench-language works237,207